Inception Return
(11/4/2011)
|
9.79 %
|
YTD Return
|
6.44 %
|
|
NAVPS
(3/27/2024)
|
$9.56
|
Change
|
$0.07 / 0.76 %
|
|
Growth of $10,000
(As of February 29, 2024)
|
MER
|
2.30 %
|
Assets ($mil)
|
$1,616.59
|
Rank (1Yr)
|
148/614
|
Std Dev (3Yr)
|
18.80 %
|
Volatility Ranking (3Yr)
|
10/10
|
RRSP Eligibility
|
Yes
|
Load
|
Front Fee Only
|
Max Front End
|
5.00 %
|
Max Back End
|
-
|
Sales Status
|
Open
|
|
Objective
The fundamental investment objective of the Fund is to obtain capital appreciation, preservation and dividend income. The Fund will invest in a diversified portfolio, of which the equity portion will be comprised of mainly Canadian and U.S. equity securities. A portion of the Fund’s assets may also be held in securities outside of North America.
|
Fund Manager
Manulife Investment Management Limited
Portfolio Manager
Conrad Dabiet, Manulife Investment Management Limited
Alan Wicks, Manulife Investment Management Limited
Prakash Chaudhari, Manulife Investment Management Limited
Jonathan Popper, Manulife Investment Management Limited
Chris Hensen, Manulife Investment Management Limited
Saurabh Moudgil, Manulife Investment Management Limited
Sub-Advisor
Data not available
|
Asset Allocation
(As of January 31, 2024)
|
Sector Allocation
(As of January 31, 2024)
|
Geographic Allocation
(As of January 31, 2024)
|
Top 10 Holdings
Name | Asset | Sector | Geographic | Percent |
Brookfield Corp Cl A | Canadian Equity | Financial Services | Canada | 0.00% |
Berkshire Hathaway Inc Cl B | US Equity | Financial Services | United States | 0.00% |
Alimentation Couche-Tard Inc | Canadian Equity | Consumer Services | Canada | 0.00% |
Microsoft Corp | US Equity | Technology | United States | 0.00% |
Aon PLC Cl A | International Equity | Financial Services | European Union | 0.00% |
Constellation Software Inc | Canadian Equity | Technology | Canada | 0.00% |
Alphabet Inc Cl A | US Equity | Technology | United States | 0.00% |
Dollar General Corp | US Equity | Consumer Services | United States | 0.00% |
Thermo Fisher Scientific Inc | US Equity | Healthcare | United States | 0.00% |
Marsh & McLennan Cos Inc | US Equity | Financial Services | United States | 0.00% |
Performance Data
(As of February 29, 2024)
|
Return (%)
|
Annualized Return (%)
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
Fund
|
3.80
|
8.74
|
8.71
|
6.44
|
18.95
|
3.99
|
6.68
|
8.45
|
Benchmark
|
3.10
|
7.47
|
8.39
|
3.95
|
12.80
|
8.28
|
9.20
|
7.80
|
Quartile Ranking
|
3
|
2
|
3
|
1
|
1
|
4
|
4
|
2
|
Calendar Return (%)
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
Fund
|
21.16
|
-27.13
|
21.24
|
22.40
|
15.36
|
-6.71
|
26.54
|
9.64
|
-2.63
|
16.14
|
Benchmark
|
13.60
|
-8.87
|
21.76
|
7.58
|
21.45
|
-7.14
|
10.80
|
14.44
|
-0.77
|
10.96
|
Quartile Ranking
|
1
|
4
|
3
|
1
|
4
|
2
|
1
|
4
|
3
|
1
|